Other publications

• L. Iconaru, M. Surquin, P. Bergmann, J.-J. Body
  Modèles de prédiction des fractures imminentes développés à partir de la cohorte frisbee
  ORTHO-RHUMATO | VOL 22 | N°2 | 2024
• L. Iconaru, M. Surquin, P. Bergmann, J.-J. Body
  Voorspellende modellen voor het risico op fracturen op basis van de frisbee-cohortstudie
  ORTHO-RHUMATO | VOL 22 | Nr2 | 2024
• O. Bruyère, C. Coendo, S. Gillain
  La prévention des chutes chez la personne âgée
  ORTHO-RHUMATO | VOL 22 | N°2 | 2024
• O. Bruyère, C. Coendo, S. Gillain
  Preventie van vallen bij ouderen
  ORTHO-RHUMATO | VOL 22 | Nr2 | 2024
• E. Cavalier
  Une approche plus dynamique du métabolisme de la vitamine d permettra-t-elle de redéfinir les standards de supplémentation?
  ORTHO-RHUMATO | VOL 22 | N°2 | 2024
• E. Cavalier
  Een dynamischere kijk op het vitamine d-metabolisme voor een herdefiniëring van vitamine d-suppletie?
  ORTHO-RHUMATO | VOL 22 | Nr2 | 2024
• A. D. Anastasilakis, J. Pepe, N. Napoli, A. Palermo, C. Magopoulos, A. A. Khan, M. C. Zillikens, J.-J. Body
  Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS
  The Journal of Clinical Endocrinology & Metabolism, 2022, 107, 1441–1460 https://doi.org/10.1210/clinem/dgab888
  Advance access publication 18 December 2021
• C. Beaudart, E. McCloskey, O. Bruyère, M. Cesari, Y. Rolland, R. Rizzoli, I. Araujo de Carvalho, J. Amuthavalli Thiyagarajan, I. Bautmans, M.C. Bertière, M. L. Brandi, N. M. Al-Daghri, N. Burlet, E. Cavalier, F. Cerreta, A. Cherubini, R. Fielding, E. Gielen, F. Landi, J. Petermans, J.Y. Reginster, M. Visser, J. Kanis, C. Cooper
  Sarcopenia in daily practice: assessment and management
  BMC Geriatrics (2016) 16:170 DOI 10.1186/s12877-016-0349-4
  Published online: 5 October 2016
• J. Dupont, L. Dedeyne, S. Dalle, K. Koppo, E. Gielen
  The role of omega-3 in the prevention and treatment of sarcopenia
  Aging Clinical and Experimental Research (2019) 31:825–836 DOI 10.1007/s40520-019-01146-1
  Published online: 19 February 2019
• MR Laurent, L. Dedeyne, J. Dupont, B. Mellaerts, M. Dejaeger, E. Gielen
  Age-related bone loss and sarcopenia in men
  Maturitas 122 (2019) 51–56
  Accepted 22 January 2019
• Laurent MR
  Bone: best papers of the year 2017
  Archives of Osteoporosis (2018) 13:29
  Published 15 March 2018
• Vandenbroucke A, Luyten FP, Flamaing J, Gielen E
  Pharmacological treatment of osteoporosis in the oldest old
  Clin Interv Aging. 2017 Jul 6;12:1065-1077. doi: 10.2147/CIA.S131023
  eCollection 2017. Review
• Fahrleitner-Pammer A, Papaioannou N, Gielen E, Feudjo Tepie M, Toffis C, Frieling I, Geusens P, Makras P, Boschitsch E, Callens J, Anastasilakis AD, Niedhart C, Resch H, Kalouche-Khalil L, Hadji P
  Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis inGermany, Austria, Greece, and Belgium
  Arch Osteoporos. 2017 Dec;12(1):58
  Published online: 22 June 2017
• Dedeyne L, Deschodt M, Verschueren S, Tournoy J, Gielen E
  Effects of multi-domain interventions in (pre)frail elderly on frailty, functional, and cognitive status: a systematic review
  Clin Interv Aging. 2017 May 24;12:873-896. doi: 10.2147/CIA.S130794
  eCollection 2017. Review
• Laurent MR, Gielen E, Pauwels S, Vanderschueren D, Bouillon R
  Hypervitaminosis D Associated With Tanning Bed Use: A Case Report
  Ann Intern Med. 2017 Jan 17;166(2):155-156. doi: 10.7326/L16-0138
• Laurent MR, Hammond GL, Blokland M, Jardí F, Antonio L, Dubois V, Khalil R, Sterk SS, Gielen E, Decallonne B, Carmeliet G, Kaufman JM, Fiers T, Huhtaniemi IT, Vanderschueren D, Claessens F
  Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis
  Sci Rep. 2016 Oct 17;6:35539
• Laurent MR, Cook MJ, Gielen E, Ward KA, Antonio L, Adams JE, Decallonne B, Bartfai G, Casanueva FF, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Lean MEJ, Lee DM, Pendleton N, Punab M, Claessens F, Wu FCW, Vanderschueren D, Pye SR, O'Neill TW; EMAS Group
  Lower bone turnover and relative bone deficits in men with metabolic syndrome: a matter of insulin sensitivity? The European Male Ageing Study
  Osteoporos Int. 2016 Nov;27(11):3227-3237
• C. Verroken, H.-G. Zmierczak, S. Goemaere, J.-M. Kaufman, B. Lapauw
  Association of Jumping Mechanography-Derived Indices of Muscle Function with Tibial Cortical Bone Geometry
  Calcif Tissue Int (2016) 98:446–455
  Published online: 16 December 2015
• C. Verroken, H.-G. Zmierczak, S. Goemaere, J.-M. Kaufman, B. Lapauw
  Insulin Resistance Is Associated With Smaller Cortical Bone Size in Nondiabetic Men at the Age of Peak Bone Mass
  J Clin Endocrinol Metab, June 2017
  First Published Online 21 December 2016
• C. Verroken, W. Pieters, L. Beddeleem, S. Goemaere, H.-G. Zmierczak, S. Shadid, J.-M. Kaufman, B. Lapauw
  Cortical Bone Size Deficit in Adult Patients With Type 1 Diabetes Mellitus
  J Clin Endocrinol Metab, August 2017
  First Published Online 22 May 2017
• F. Buckinx, J-Y. Reginster, T. Brunois, C. Lenaerts, C. Beaudart, J-L. Croisier, J. Petermans, O. Bruyère
  Prevalence of sarcopenia in a population of nursing home residents according to their frailty status: results of the SENIOR cohort
  Journal of Musculoskeletal and Neuronal Interactions
  2017
• F. Buckinx MSc, J.-L. Croisier PhD, J.-Y. Reginster MD, PhD, C. Lenaerts MSc, T. Brunois MSc, X. Rygaert MSc, J. Petermans MD, PhD, O. Bruyère PhD
  Prediction of the Incidence of Falls and Deaths Among Elderly Nursing Home Residents: The SENIOR Study
  2017 AMDA e The Society for Post-Acute and Long-Term Care Medicine.
• S. Rozenberg, J. Vandromme and C. Antoine
  Postmenopausal hormone therapy: risks and benefits
  Rozenberg, S. et al. Nat. Rev. Endocrinol. 9, 216–227 (2013)
  published online 19 February 2013
• M. Locquet, G. Honvo, V. Rabenda, T. Van Hees, J. Petermans, J.-Y. Reginster, O. Bruyère
  Adverse Health Events Related to Self-Medication Practices Among Elderly: A Systematic Review
  Springer International Publishing Switzerland 2017
  Published online: 28 February 2017
• A. Mouton, N. Gillet, F. Mouton, D. Van Kann, O. Bruyère, M. Cloes, F. Buckinx
  Effects of a giant exercising board game intervention on ambulatory physical activity among nursing home residents: a preliminary study
  Clinical Interventions in Aging 2017:12 847–858
  Published online: 22 May 2017
• C. Beaudart, M. Zaaria, F. Pasleau, J.-Y. Reginster, O. Bruyère
  Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis
  PLoS ONE 12(1): e0169548
  Published: January 17, 2017
• O. Bruyère, F. Buckinx, C. Beaudart, J.-Y. Reginster, J. Bauer, T. Cederholm, A. Cherubini, C. Cooper, A. J. Cruz-Jentoft, F. Landi, S. Maggi, R. Rizzoli, A. A. Sayer, C. Sieber, B. Vellas, M. Cesari on behalf of ESCEO and the EUGMS frailty working group
  How clinical practitioners assess frailty in their daily practice: an international survey
  Aging Clin Exp Res
  Published online: 02 August 2017
• F. Buckinx, J.-Y. Reginster, A. Morelle, N. Paquot, N. Labeye, M. Locquet, S. Adam, O. Bruyère
  Influence of environmental factors on food intake among nursing home residents: a survey combined with a video approach
  Clinical Interventions in Aging 2017:12
  Published: 4 July 2017
• C. Beaudart, A. Dawson, S. C. Shaw, N. C. Harvey, J. A. Kanis, N. Binkley, J. Y. Reginster, R. Chapurlat, D. C. Chan, O. Bruyère, R. Rizzoli, C. Cooper, E. M. Dennison, the IOF-ESCEO Sarcopenia Working Group
  Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review
  Osteoporos Int (2017) 28:1817–1833
  Published online: 1 March 2017
• A.-F. Rousseau, E. Cavalier, J.-Y. Reginster, P. Damas, O. Bruyère
  Occurrence of Clinical Bone Fracture Following a Prolonged Stay in Intensive Care Unit: A Retrospective Controlled Study
  Calcif Tissue Int
  Published online: 10 July 2017
• F. Buckinx MSc, J.-L. Croisier PhD, J.-Y. Reginster MD, PhD, C. Lenaerts MSc, T. Brunois MSc, X. Rygaert MSc, J. Petermans MD, PhD, O. Bruyère PhD
  Prediction of the Incidence of Falls and Deaths Among Elderly Nursing Home Residents: The SENIOR Study
  JAMDA xxx (2017) 1-7
  2017
• M. LOCQUET, C. BEAUDART, J.-Y. REGINSTER, J. PETERMANS, S. GILLAIN, A. QUABRON, J. SLOMIAN, F. BUCKINX, O. BRUYÈRE
  Prelevance of concomitant bone and muscle wasting in elderly women from the sarcophage cohort: preliminary results
  The Journal of Frailty & Aging©
  Accepted for publication June 28, 2016
• F. BUCKINX, J.-Y. REGINSTER, S. GILLAIN, J. PETERMANS, T. BRUNOIS, O. BRUYÈRE
  Prevalence of frailty in nursing home residents according to various diagnostic tools
  The Journal of Frailty & Aging©
  Accepted for publication March 9, 2017
• F. Buckinx, J.-Y. Reginster, T. Brunois, C. Lenaerts, C. Beaudart, J.-L. Croisier, J. Petermans, O. Bruyère
  Prevalence of sarcopenia in a population of nursing home residents according to their frailty status: results of the SENIOR cohort
  Journal of Musculoskeletal and Neuronal Interactions
  Accepted 20 June 2017
• C. Beaudart, E. Biver, O. Bruyère, C. Cooper, N. Al-Daghri, J.-Y. Reginster & R. Rizzoli
  Quality of life assessment in musculoskeletal health
  Aging Clin Exp Res
  Published online: 29 June 2017
• O. Bruyère, J.Y. Reginster, N. Dardenne, J. Nelis, E. Lambert, G. Appelboom, F. Buckinx
  Relationship between ambulatory physical activity assessed by activity trackers and physical frailty among nursing home residents
  The Journal of Nursing Home Research Sciences
  Volume 1, 2015
• O. Bruyèrea, P. Bergmannb, E. Cavalierc, E. Gielend, S. Goemaeree, J.-M. Kaufmanf, S. Rozenbergg, J-J Bodyh
  Skeletal health in breast cancer survivors
  Maturitas
  Accepted 11 August 2017
• O. Ethgen, C. Beaudart, F. Buckinx, O. Bruyère, J.-Y. Reginster
  The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action
  Calcif Tissue Int (2017) 100:229–234
  Published online: 24 December 2016
• O. Bruyère, E. Cavalier, J.-Y. Reginster
  Vitamin D and osteosarcopenia: an update from epidemiological studies
  Curr Opin Clin Nutr Metab Care 2017, 20:000–000
  Volume 20 - Number 00 - Month 2017
• Michaël R. Laurent, Ferran Jardí, Vanessa Dubois, Dieter Schollaert, RouginKhalil, Evelien Gielen, Geert Carmeliet, Frank Claessens, Dirk Vanderschueren
  Androgens have antiresorptive effects on trabecular disuse osteopenia independent from muscle atrophy
  Bone 93 (2016) 33–42
• Michael J. Cook, Alexander Oldroyd, Stephen R. Pye, Kate A. Ward, Evelien Gielen, Rathi Ravindrarajah, Judith E. Adams, David M. Lee, Gyorgy Bartfai, Steven Boonen, Felipe Casanueva, Gianni Forti, Aleksander Giwercman, Thang S. Han, Ilpo T. Huhtaniemi, Krzysztof Kula, Michael E. Lean, Neil Pendleton, Margus Punab, Dirk Vanderschueren, Frederick C. Wu, Terence W. O’Neill for the EMAS study group
  Frailty and bone health in European men
  Age and Ageing 2016; 0: 1–7
• Katy J.L. Bell, Andrew Hayen, Paul Glasziou, Les Irwig, Douglas C. Bauer
  Change in Bone Mineral Density Is an Indicator of Treatment-Related Antifracture Effect
  Annals of Internal Medicine • Vol. 166 No. 2
  2017
• S. R. Pye, K. A. Ward, M. J. Cook, M. R. Laurent, E. Gielen, H. Borghs, J. E. Adams, S. Boonen, D. Vanderschueren, F. C. Wu, T. W. O’Neill
  Bone turnover predicts change in volumetric bone density and bone geometry at the radius in men
  Osteoporos Int (2017) 28:935–944
• Evelien Gielen, Terence W. O’Neill, Stephen R. Pye, Judith E. Adams, Frederick C. Wu, Michaël R. Laurent, Frank Claessens, Kate A. Ward, Steven Boonen, Roger Bouillon, Dirk Vanderschueren, Sabine Verschueren
  Endocrine determinants of incident sarcopenia in middle-aged and elderly European men
  Journal of Cachexia, Sarcopenia and Muscle 2015; 6: 242–252
• H.A. Morris, R. Eastell, N.R. Jorgesen, E. Cavalier, S. Vasikaran, S.A.P. Chubb, J.A. Kanis, C. Cooper, K. Makris, on behalf of the IFCC-IOFWorking Group for Standardisation of Bone Marker Assays (WG-BMA)
  Clinical usefulness of bone turnover marker concentrations in osteoporosis
  CCA-14426
  2016
• Anne-Françoise Rousseau, Pierre Damas, Pierre Delanaye, Etienne Cavalier
  Bone markers during acute burn care: Relevance to clinical practice?
  JBUR-5007;
  2016
• Guillaume Jean, Charles Chazot, Eric Bresson, Eric Zaoui, Etienne Cavalier
  High Serum Sclerostin Levels Are Associated with a Better Outcome in Haemodialysis Patients
  Nephron
  2016
• J.-C. Souberbielle, F. Brazier, M.-L. Piketty, C. Cormier, S. Minisola, E. Cavalier
  How the reference values for serum parathyroid hormone concentration are (or should be) established?
  J Endocrinol Invest
  2016
• E. Cavalier, B. Jandrain, M. Coffiner, S. Da Silva, S. De Niet, F. Vanderbist, J.-C. Souberbielle
  A Randomised, Cross-Over Study to Estimate the Influence of Food on the 25-Hydroxyvitamin D₃ Serum Level after Vitamin D₃ Supplementation
  Nutrients 2016, 8, 309
• J.-C. Souberbielle, C. Massart, S. Brailly-Tabard, C. Cormier, E. Cavalier, P. Delanaye and P. Chanson
  Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients
  European Journal of Endocrinology
  2016
• R. von Moos, J.-J. Body, B. Egerdie, A. Stopeck, J. Brown, L. Fallowfield, D. L. Patrick, C. Cleeland, D. Damyanov, F. S. Palazzo, G. Marx, Y. Zhou, A. Braun, A. Balakumaran, Y. Qian
  Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases
  Support Care Cancer (2016) 24:1327–1337
• J.J. Body, E. Terpos, B. Tombal, P. Hadji, A. Arif, A. Young, M. Aapro, R. Coleman
  Bone health in the elderly cancer patient: A SIOG position paper
  Cancer Treatment Reviews 51 (2016) 46–53
• J.-J. Body
  Traitements inhibiteurs de la résorption osseuse en situation métastatique : bilan actuel et perspectives
  Oncologie (2015) 17:117-126
• A. T. Stopeck, K. Fizazi, J.-J. Body, J. E. Brown, M. Carducci, I. Diel, Y. Fujiwara, M. Martín, A. Paterson, K. Tonkin, N. Shore, P. Sieber, F. Kueppers, L. Karsh, D. Yardley, H. Wang, T. Maniar, J. Arellano, A. Braun
  Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer
  Support Care Cancer (2016) 24:447–455
• G. Hechmati, A. Brett Hauber, J. Arellano, A. F. Mohamed, Y. Qian, F. Gatta, I. Haynes, A. Bahl, R. von Moos, J.-J. Body
  Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom
  Support Care Cancer (2015) 23:21–28
• E. Cavalier, P. Bergmann, O. Bruyère, P. Delanaye, A. Durnez, J.-P. Devogelaer, S. L. Ferrari, E. Gielen, S. Goemaere, J.-M. Kaufman, A. Nzeusseu Toukap, J.-Y. Reginster, A.-F. Rousseau, S. Rozenberg, A. J. Scheen, J.-J. Body
  The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club
  Osteoporos Int
  2015
• V. V. Yerganyan, J.-J. Body, N. De Saint Aubain, M. Gebhart
  Gorham–Stout disease of the proximal fibula treated with radiotherapy and zoledronic acid
  Journal of Bone Oncology 4 (2015) 42–46
• J.-J. Body, J. Pereira, H. Sleeboom, N. Maniadakis, E. Terpos, Y. P. Acklin, J. Finek, O. Gunther, G. Hechmati, T. Mossman, L. Costa, W. Rogowski, H. Nahi, R. von Moos
  Health resource utilization associated with skeletal-related events: results from a retrospective European study
  Eur J Health Econ
  2015
• I. J. Diel, J.-J. Body, A. T. Stopeck, S. Vadhan-Raj, A. Spencere, G. Stegerf, R. von Moosg, F. Goldwasserh, A. Feng, A. Braun
  The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease
  European Journal of Cancer (2015) 51, 1467– 1475
• J.-J. Body, H. G. Bone, R. H. de Boer, A. Stopeck, C. Van Poznak, R. Damião, K. Fizazi, D. H. Henry, T. Ibrahim, A. Lipton, F. Saad, N. Shore, T. Takano, A. J. Shaywitz, H. Wang, O. L. Bracco, A. Braun, P. J. Kostenuik
  Hypocalcaemia in patients with metastatic bone disease treated with denosumab
  European Journal of Cancer (2015) 51, 1812– 1821
• S. Rozenberg, J.-J. Body, O. Bruyère, P. Bergmann, M. L. Brandi, C. Cooper, J.-P. Devogelaer, E. Gielen, S. Goemaere, J.-M. Kaufman, R. Rizzoli, J.-Y. Reginster
  Effects of Dairy Products Consumption on Health: Benefits and Beliefs - A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
  Calcif Tissue Int (2016) 98:1–17
• J.-J. Body, S. Casimiro, L. Costa
  Targeting bone metastases in prostate cancer: improving clinical outcome
  Body, J.-J. et al. Nat. Rev. Urol. 12, 340–356 (2015)
• P. Hadji, R. E. Coleman, C. Wilson, T. J. Powles, P. Clézardin, M. Aapro, L. Costa, J.-J. Body, C. Markopoulos, D. Santini, I. Diel, A. Di Leo, D. Cameron, D. Dodwell, I. Smith, M. Gnant, R. Gray, N. Harbeck, B. Thurlimann, M. Untch, J. Cortes, M. Martin, U.-S. Albert, P.-F. Conte, B. Ejlertsen, J. Bergh, M. Kaufmann, I. Holen
  Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
  Annals of Oncology 27: 379–390, 2016
• Neuprez A, Bruyère O, Maheu E, Dardenne N, Burlet N, D’Hooghe P, Distèche S and Reginster JY
  Aesthetic discomfort in hand osteoarthritis: results from the LIège Hand Osteoarthritis Cohort (LIHOC)
  Arthritis Research & Therapy Volume 17: 346, 2015.
• Gielen E, O'Neill T, Pye S, Adams J, Ward K, Wu F, Laurent M, Claessens F, Boonen S, Vanderschueren D, Verschueren S.
  Bone turnover markers predict hip bone loss in elderly European men: results of the European Male Ageing Study (EMAS)
  Osteoporosis International Volume 26 Issue 2: 617–627, 2015.
• Beaudart C, Reginster JY, Slomian J, Buckinx F, Dardenne N, Quabron A, Slangen C, Gillain S, Petermans J, Bruyère O.
  Estimation of sarcopenia prevalence using various assessment tools
  Experimental Gerontology 61: 31–37, 2015.
• Lips P, Gielen E and Van Schoor NM.
  Vitamin D supplements with or without calcium to prevent fractures
  BoneKEy Reports 3 Article number 512, 2014.
• Kanis JA, McCloskey E, Branco J, Brandi ML, Dennison E, Devogelaer JP, Ferrari S, Kaufman JM, Papapoulos S, Reginster JY, Rizzoli R.
  Goal-directed treatment of osteoporosis in Europe
  Osteoporosis International Volume 25 Issue 11: 2533-2543, 2014.
• Reginster JY, Neuprez A, Beaudart C, Buckinx F, Slomian J, Disteche S, Bruyère O.
  Bone forming agents for the management of osteoporosis
  Panminerva Medica Volume 56 Issue 2: 97-114, 2014.
• Bruyère O, Cooper C, Pelletier JP, Branco J, Brandi ML, Guillemin F, Hochberg MC, Kanis JA, Kvien TK, Martel-Pelletier J, Rizzoli R, Silverman S, Reginster JY.
  An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
  Seminars in Arthritis and Rheumatism Volume 44 Issue 3: 253-263, 2014.
• Hiligsmann M, Cooper C, Guillemin F, Hochberg MC, Tugwell P, Arden N, Berenbaum F, Boers M, Boonen A, Branco JC, Brandi ML, Bruyère O, Gasparik A, Kanis JA, Kvien TK, Martel-Pelletier J, Pelletier JP, Pinedo-Villanueva R, Pinto D, Reiter-Niesert S, Rizzoli R, Rovati LC, Severens JL, Silverman S, Reginster JY.
  A reference case for economic evaluations in osteoarthritis: An expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
  Seminars in Arthritis and Rheumatism Volume 44 Issue 3: 271-282, 2014.
• Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J, Petermans J, Reginster JY, Bruyère O.
  The effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a systematic review and meta-analysis of randomized controlled trials
  The Journal of Clinical Endocrinology & Metabolism Volume 99 Issue 11: 4336-4345, 2014.
• Bruyère O, Reginster JY.
  Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome
  New York, NY: Springer Science+Business Media, 2014.
• Bruyère O, Reginster JY.
  Monitoring of osteoporosis therapy
  Best Practice & Research Clinical Endocrinology & Metabolism 28: 835-841, 2014.
• Reginster JY, Neuprez A, Dardenne N, Beaudart C, Emonts P, Bruyere O.
  Efficacy and safety of currently marketed anti-osteoporosis medications
  Best Practice & Research Clinical Endocrinology & Metabolism 28: 809-834, 2014.
• Bruyère O, Cavalier E, Souberbielle JC, Bischoff-Ferrari HA, Beaudart C, Buckinx F, Reginster JY, Rizzoli R.
  Effects of vitamin D in the elderly population: current status and perspectives
  Archives of Public Health Volume 72 Issue 32, 2014.
• Slomian J, Appelboom G, Ethgen O, Reginster JY, Bruyère O.
  Can new information and communication technologies help in the management of osteoporosis?
  Women’s Health Volume 10 Issue 3: 229–232, 2014.
• Rizzoli R, Branco J, Brandi ML, Boonen S, Bruyère O, Cacoub P, Cooper C, Diez-Perez A, Duder J, Fielding RA, Harvey NC, Hiligsmann M, Kanis JA, Petermans J, Ringe JD, Tsouderos Y, Weinman J, Reginster JY.
  Management of osteoporosis of the oldest old
  Osteoporosis International 25: 2507–2529, 2014.
• The role of the dairy products in the prevention of osteoporosis in Belgium (FR)
  
• The role of the dairy products in the prevention of osteoporosis in Belgium (NL)
  
• Bouillon R, Van Schoor NM, Gielen E, Boonen S, Mathieu C, Vanderschueren D, Lips P. Optimal Vitamin D Status: A Critical Analysis on the Basis of Evidence-Based Medicine. Journal of Clinical Endocrinology and Metabolism Volume 98 Issue 8: E1283-E1304, 2013.
• Laurent M, Gielen E, Claessens F, Boonen S, Vanderschueren D. Osteoporosis in older men: Recent advances in pathophysiology and treatment. Best Practice & Research Clinical Endocrinology & Metabolism Volume 27 Issue 4: 527–539, 2013.
• Verschueren S, Gielen E, O'Neill TW, Pye SR, Adams JE, Ward KA, Wu FC, Szulc P, Laurent M, Claessens F, Vanderschueren D, Boonen S. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporosis International Volume 24 Issue 1: 87-98, 2013.
• Beaudart C, Maquet D, Mannarino M, Buckinx F, Demonceau M, Crielaard JM, Reginster JY, Bruyère O. Effects of 3 months of short sessions of controlled whole body vibrations on the risk of falls among nursing home residents. BMC Geriatrics Volume 13 Issue 42, 2013.
• Buckinx F, Beaudart C, Maquet D, Demonceau M, Crielaard JM, Reginster JY, Bruyère O. Evaluation of the impact of 6-month training by whole body vibration on the risk of falls among nursing home residents, observed over a 12-month period: a single blind, randomized controlled trial. Aging Clinical and Experimental Research Volume 26 Issue 4: 369-376, 2013.
• Bishop N, Adami S, Ahmed SF, Antón J, Arundel P, Burren CP, Devogelaer JP, Hangartner T, Hosszú E, Lane JM, Lorenc R, Mäkitie O, Munns CF, Paredes A, Pavlov H, Plotkin H, Raggio CL, Reyes ML, Schoenau E, Semler O, Sillence DO, Steiner RD. Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial. Lancet 382: 1424–1432, 2013.
• Rizzoli R, Reginster JY, Arnal JF, Bautmans I, Beaudart C, Bischoff-Ferrari H, Biver E, Boonen S, Brandi ML, Chines A, Cooper C, Epstein S, Roger A. Fielding, Goodpaster B, Kanis JA, Kaufman JM, Laslop A, Malafarina V, Mañas LR, Mitlak BH, Oreffo RO, Petermans J, Reid K, Rolland Y, Sayer AA, Tsouderos Y, Visser M, Bruyère O. Quality of Life in Sarcopenia and Frailty. Calcified Tissue International 93: 101–120, 2013.
• Mathieu M, Rigutto S, Ingels A, Spruyt D, Stricwant N, Kharroubi I, Albarani V, Jayankura M, Rasschaert J, Bastianelli E, Gangji V. Decreased pool of mesenchymal stem cells is associated with altered chemokines serum levels in atrophic nonunion fractures. Bone Volume 53 Issue 2: 391-398, 2013.
• Boonen S, Luyten F, Vanderschueren D, Gielen E, Borghs H, Goemaere S. Medische preventie van osteoporotische breuken bij patiënten behandeld met glucocorticoïden. Tijdschrift voor Geneeskunde Volume 68 Issue 12: 612-620, 2012.
• Verbrugge FH, Gielen E, Milisen K, Boonen S. Who should receive calcium and vitamin D supplementation?. Age and Ageing Volume 41 Issue 5: 576-580, 2012.
• Gielen E, Verschueren S, O'Neill TW, Pye SR, O'Connell MD, Lee DM, Ravindrarajah R, Claessens F, Laurent M, Milisen K, Tournoy J, Dejaeger M, Wu FC, Vanderschueren D, Boonen S. Musculoskeletal Frailty: A Geriatric Syndrome at the Core of Fracture Occurrence in Older Age. Calcified Tissue International Volume 91 Issue 3: 161–177, 2012.
• Bruyère O, Nicolet D, Compère S, Rabenda V, Jeholet P, Zegels B, Maassen P, Pire G, Reginster JY. Perception, knowledge, and use by general practitioners of Belgium of a new WHO tool (FRAX) to assess the 10-year probability of fracture. Rheumatology International Volume 33 Issue 4: 979–983, 2012.
• Rabenda V, Bruyère O, Reginster JY. Risk of nonvertebral fractures among elderly postmenopausal women using antidepressants. Bone Volume 51, Issue 4: 674–679, 2012.
• Bruyère O, Fossi M, Zegels B, Leonori L, Hiligsmann M, Neuprez A, Reginster JY. Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security and the new suggested FRAX criteria. Rheumatology International Volume 33 Issue 4: 973-978, 2012.
• Bruyère O, Nicolet D, Compère S, Rabenda V, Jeholet P, Zegels B, Maassen P, Pire G, Reginster JY. Perception, knowledge, and use by general practitioners of Belgium of a new WHO tool (FRAX) to assess the 10-year probability of fracture. Rheumatology International Volume 33 Issue 4: 979-983, 2012.
• Bruyère O, Detilleux J, Chines A, Reginster JY. Relationships Between Changes in Bone Mineral Density or Bone Turnover Markers and Vertebral Fracture Incidence in Patients Treated with Bazedoxifene. Calcified Tissue International 91: 244–249, 2012.
• Hiligsmann M, Bruyère O, Roberfroid D, Dubois C, Parmentier Y, Carton J, Detilleux J, Gillet P, Reginster JY. Trends in hip fracture incidence and in the prescription of antiosteoporosis medications during the same time period in Belgium (2000-2007). Arthritis Care & Research Volume 64 Issue 5: 744-750, 2012.
• Dejaeger M, Gielen E, Vandewoude M, Milisen K, Laurent M, Vanderschueren D, Claessens F, Flamaing J, Verschueren S, Boonen S. Broosheid bij ouderen of "frailty": het geriatrisch kernsyndroom ontleed. Tijdschrift voor Geneeskunde Volume 67 Issue 22: 1059–1070, 2011.
• Gielen E, Vanderschueren D, Callewaert F, Boonen S. Osteoporosis in men. Best Practice & Research Clinical Endocrinology & Metabolism Volume 25 Issue 2: 321–335, 2011.
• Bergmann P, Body JJ, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman J, Reginster, JY Rozenberg S. Loading and skeletal development and maintenance. Journal of Osteoporosis 11: 786752, 2011.
• Rabenda V, Nicolet D, Beaudart C, Bruyère O, Reginster JY. Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporosis International 24: 121–137, 2011.
• Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year follow-up of a prospective controlled study. Bone Volume 49 Issue 5: 1005–1009, 2011.
• Callewaert F, Sinnesael M, Gielen E, Boonen S, Vanderschueren D. Skeletal sexual dimorphism: relative contribution of sex steroids, GH–IGF1, and mechanical loading. Journal of Endocrinology Volume 207 Issue 2: 127–134, 2010.
• Johansson H, Kanis JA, McCloskey EV, Odén A, Devogelaer JP, Kaufman JM, Neuprez A, Hiligsmann M, Bruyere O, Reginster JY. Publication validation FRAX tool Belgium. Osteoporosis International 22: 453–461, 2009.
• Orwoll E, Bilezikian J, Vanderschueren D. Osteoporosis in Men: The Effects of Gender on Skeletal Health. Waltham, MA: Academic Press, 2009.

Section 1 -   Essentials of bone biology
Section 2 -   Development and growth of the male skeleton
Section 3 -   Skeletal genetics
Section 4 -   Aging and the male skeleton
Section 5 -   Nutritional issues
Section 6 -   Sex steroids and the skeleton in men
Section 7 -   Fractures in men
Section 8 -   Metabolic bone disease in men
Section 9 -   Diagnostic approach
Section 10 - Therapy

• Bruyere O, De Cock C, Mottet C, Neuprez A, Malaise O, Reginster JY. Low dietary calcium in European postmenopausal osteoporotic women. Public Health Nutrition Volume 12 Issue 1: 111–114, 2007.
• Bruyere O, Malaise O, Neuprez A, Collette J, Reginster JY. Prevalence of vitamin D inadequacy in European postmenopausal woman. Current Medical Research and Opinion Volume 23 Issue 8: 1939-1944, 2007.
• Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M. Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologus Bone-Marrow Cells. The Journal of Bone and Joint Surgery Volume 86 Issue 6: 1153-1160, 2004.
• The IOF has launched a free online review journal to keep you abreast of the latest research in osteoporosis.